Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 1/2021

23.05.2020

Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center

verfasst von: Megan Kunka Fritz, Scott E. Kincaid, Charles G. Sargent, Amanda H. Green, George A. Davis

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Hospital-acquired venous thromboembolism (VTE) is still a concern for general medical patients. Pharmacologic prophylaxis can reduce VTE incidence, but there is the potential for adverse effects. Therefore, determining which patients should receive VTE prophylaxis via risk scoring tools is essential. Limited evidence exists for the ideal venous thromboembolism risk assessment model (RAM) in hospitalized medical patients, as compared to other hospitalized patient subgroups such as surgical patients. The primary objective was to investigate the utilization and appropriateness of our institution-based VTE RAM and comparison to the Padua Prediction Score (PPS). This would allow for a gauge of provider risk assessment accuracy as well as appropriate predictive potential of the PPS or whether an alternative to the PPS should be considered. A total of 330 adult general medicine patients were included in this retrospective chart review. When compared to our institution-based VTE RAM, providers predominately stratified patients at a higher VTE risk than the institution-based VTE RAM. VTE incidence was 0.3%, which was lower than predicted. Significant discordance exists between providers’ VTE risk assessment and that predicted by RAMs. Our institution-based VTE RAM appears comparable to PPS; however, it was not being utilized by providers, resulting in potentially unnecessary use of pharmacologic prophylaxis.
  • The most appropriate venous thromboembolism risk assessment model for general medicine patients is undetermined.
  • Our providers generally assess patients as moderate or high VTE risk, despite our institution-based RAM which typically recommends a lower risk category than provider selection.
  • Because of provider risk assessment, more patients received pharmacologic VTE prophylaxis than would have been recommended by the RAM, which might correlate to the low incidence of VTE which was < 0.5%, although bleeding complications were not assessed in this study.
  • A prospective study utilizing the Padua Prediction Score (or similar RAM) in general medicine patients is warranted in order to decipher the best method of predicting VTE risk.
Literatur
1.
Zurück zum Zitat Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:381S–453SCrossRef Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:381S–453SCrossRef
2.
Zurück zum Zitat Kessler CM, Cap AP (2009) Prevention of venous thromboembolism in hospitalized medical patients. Cancer Invest 27:17–27CrossRef Kessler CM, Cap AP (2009) Prevention of venous thromboembolism in hospitalized medical patients. Cancer Invest 27:17–27CrossRef
3.
Zurück zum Zitat Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809–815CrossRef Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809–815CrossRef
4.
Zurück zum Zitat National Institute for Health and Clinical Excellence (2010) Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE clinical guideline no. 92. Royal College of Physicians, London, pp 1–519 National Institute for Health and Clinical Excellence (2010) Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE clinical guideline no. 92. Royal College of Physicians, London, pp 1–519
5.
Zurück zum Zitat Rosenberg D, Eichorn A, Alarcon M, McCullagh L, McGinn T, Spyropoulos AC (2014) External validation of the risk assessment model of the international medical prevention registry on venous thromboembolism (IMPROVE) for medical patients in a tertiary health system. J Am Heart Assoc 3:1–7CrossRef Rosenberg D, Eichorn A, Alarcon M, McCullagh L, McGinn T, Spyropoulos AC (2014) External validation of the risk assessment model of the international medical prevention registry on venous thromboembolism (IMPROVE) for medical patients in a tertiary health system. J Am Heart Assoc 3:1–7CrossRef
6.
Zurück zum Zitat Francis CW (2007) Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med 356:1438–1444CrossRef Francis CW (2007) Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med 356:1438–1444CrossRef
7.
Zurück zum Zitat Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S–400SCrossRef Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S–400SCrossRef
8.
Zurück zum Zitat Deitelzweig SB, Sasahara A, Michota F, McKean SC, Jacobson A (2009) Guidelines-based use of thromboprophylaxis. J Hosp Med 4:S8–S15CrossRef Deitelzweig SB, Sasahara A, Michota F, McKean SC, Jacobson A (2009) Guidelines-based use of thromboprophylaxis. J Hosp Med 4:S8–S15CrossRef
9.
Zurück zum Zitat Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 146:278–288CrossRef Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 146:278–288CrossRef
10.
Zurück zum Zitat Bhalla R, Berger MA, Reissman SH et al (2013) Improving hospital venous thromboembolism prophylaxis with electronic decision support. J Hosp Med 8:115–120CrossRef Bhalla R, Berger MA, Reissman SH et al (2013) Improving hospital venous thromboembolism prophylaxis with electronic decision support. J Hosp Med 8:115–120CrossRef
11.
Zurück zum Zitat Rothberg MB, Lindenauer PK, Lahti M, Pekow PS, Selker HP (2011) Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med 6:202–209CrossRef Rothberg MB, Lindenauer PK, Lahti M, Pekow PS, Selker HP (2011) Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med 6:202–209CrossRef
12.
Zurück zum Zitat Spyropoulos AC, Anderson FA Jr, Fitzgerald G et al (2011) Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140:706–714CrossRef Spyropoulos AC, Anderson FA Jr, Fitzgerald G et al (2011) Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140:706–714CrossRef
13.
Zurück zum Zitat Barbar S, Noventa F, Rossetto V et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8:2450–2457CrossRef Barbar S, Noventa F, Rossetto V et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8:2450–2457CrossRef
14.
Zurück zum Zitat Cohen AT, Tapson VF, Bergmann JF et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371:387–394CrossRef Cohen AT, Tapson VF, Bergmann JF et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371:387–394CrossRef
15.
Zurück zum Zitat Kahn SR, Panju A, Geerts W et al (2007) Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 119:145–155CrossRef Kahn SR, Panju A, Geerts W et al (2007) Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 119:145–155CrossRef
16.
Zurück zum Zitat Pai M, Lloyd NS, Cheng J et al (2013) Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci 8:1–11CrossRef Pai M, Lloyd NS, Cheng J et al (2013) Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci 8:1–11CrossRef
17.
Zurück zum Zitat Tapson VF, Decousus H, Pini M et al (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism. Chest 132:936–945CrossRef Tapson VF, Decousus H, Pini M et al (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism. Chest 132:936–945CrossRef
18.
Zurück zum Zitat Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e195S–226SCrossRef Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e195S–226SCrossRef
19.
Zurück zum Zitat Vardi M, Ghanem-Zoubi NO, Zidan R, Yurin V, Bitterman H (2012) Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments. J Thromb Haemost 11:467–473CrossRef Vardi M, Ghanem-Zoubi NO, Zidan R, Yurin V, Bitterman H (2012) Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments. J Thromb Haemost 11:467–473CrossRef
20.
Zurück zum Zitat Schünemann HJ, Cushman M, Burnett M et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2(22):3198–3225CrossRef Schünemann HJ, Cushman M, Burnett M et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2(22):3198–3225CrossRef
21.
Zurück zum Zitat Maynard GA, Morris TA, Jenkins IH et al (2010) Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med 5:10–18PubMed Maynard GA, Morris TA, Jenkins IH et al (2010) Optimizing prevention of hospital-acquired venous thromboembolism (VTE): prospective validation of a VTE risk assessment model. J Hosp Med 5:10–18PubMed
22.
Zurück zum Zitat Kucher N, Koo S, Quiroz R et al (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352:969–977CrossRef Kucher N, Koo S, Quiroz R et al (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352:969–977CrossRef
23.
Zurück zum Zitat Streiff MB, Carolan HT, Hobson DB et al (2012) Lessons from the Johns Hopkins multi-disciplinary venous thromboembolism (VTE) prevention collaborative. BMJ 344:e3935CrossRef Streiff MB, Carolan HT, Hobson DB et al (2012) Lessons from the Johns Hopkins multi-disciplinary venous thromboembolism (VTE) prevention collaborative. BMJ 344:e3935CrossRef
24.
Zurück zum Zitat Flanders SA, Greene T, Grant P et al (2014) Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: a cohort study. JAMA Intern Med 174:1577–1584CrossRef Flanders SA, Greene T, Grant P et al (2014) Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism: a cohort study. JAMA Intern Med 174:1577–1584CrossRef
25.
Zurück zum Zitat Kakkar AK, Cimminiello C, Goldhaber SZ, Parakh R, Wang C, Bergmann JF (2011) Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med 365:2463–2472CrossRef Kakkar AK, Cimminiello C, Goldhaber SZ, Parakh R, Wang C, Bergmann JF (2011) Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med 365:2463–2472CrossRef
26.
Zurück zum Zitat Blondon M, Righini M, Nendaz M et al (2019) External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort. J Thromb Haemost 18(3):676–680CrossRef Blondon M, Righini M, Nendaz M et al (2019) External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort. J Thromb Haemost 18(3):676–680CrossRef
Metadaten
Titel
Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center
verfasst von
Megan Kunka Fritz
Scott E. Kincaid
Charles G. Sargent
Amanda H. Green
George A. Davis
Publikationsdatum
23.05.2020
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 1/2021
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02144-1

Weitere Artikel der Ausgabe 1/2021

Journal of Thrombosis and Thrombolysis 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.